SEC
UTHR icon

Seven Eight Capital’s United Therapeutics UTHR Stock Holding History

Seven Eight Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,585
Closed -$823K – 959
2024
Q2 		$823K Sell
2,585
-2,107
-45% -$558K 0.09% 410
2024
Q1 		$1.08M Buy
+4,692
New +$1.06M 0.11% 281
2022
Q2 		– Sell
-1,998
Closed -$358K – 634
2022
Q1 		$358K Buy
+1,998
New +$381K 0.05% 379
2020
Q2 		– Sell
-5,500
Closed -$522K – 569
2020
Q1 		$522K Sell
5,500
-25,287
-82% -$2.4M 0.13% 207
2019
Q4 		$2.71M Buy
30,787
+5,300
+21% +$466K 0.14% 220
2019
Q3 		$2.03M Sell
25,487
-42,500
-63% -$3.42M 0.11% 283
2019
Q2 		$5.31M Buy
67,987
+57,300
+536% +$5.36M 0.28% 111
2019
Q1 		$1.25M Buy
+10,687
New +$1.25M 0.07% 327
2016
Q2 		– Sell
-3,202
Closed -$357K – 679
2016
Q1 		$357K Buy
+3,202
New +$405K 0.15% 204
2015
Q4 		– Sell
-1,702
Closed -$223K – 693
2015
Q3 		$223K Buy
1,702
+1,200
+239% +$192K 0.19% 177
2015
Q2 		$87K Buy
+502
New +$90.3K 0.1% 276
2014
Q3 		– Sell
-300
Closed -$27K – 683
2014
Q2 		$27K Buy
+300
New +$28.9K 0.03% 424
2014
Q1 		– Sell
-500
Closed -$57K – 510
2013
Q4 		$57K Buy
+500
New +$45.1K 0.06% 382

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Seven Eight Capital's UTHR Position: Q3 2024 in Review

Seven Eight Capital sold out of United Therapeutics (UTHR) in Q3 2024, closing a stake of 2,585 shares — an estimated $823K sold.

Seven Eight Capital first reported a position in UTHR in Q4 2013 and held it in 13 quarters. The position peaked at $5.31M in Q2 2019. 624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • Seven Eight Capital reported no remaining United Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Seven Eight Capital sold 2,585 United Therapeutics shares in Q3 2024, an estimated $823K.
  • Seven Eight Capital first reported a position in United Therapeutics in Q4 2013 and held it in 13 quarters.
  • Seven Eight Capital's United Therapeutics position peaked at $5.31M in Q2 2019.
  • 624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Seven Eight Capital's 13F filing for Q3 2024, filed 12 Nov 2024.